Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
December 05, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most...
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
November 27, 2023 13:12 ET
|
alwaysAI
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
Neuroscience Market to Hit USD 65.8 Billion by 2030 Owing to Increasing Prevalence of Neurological Disorders and Collaborative Research Initiatives | Research by SNS Insider
November 20, 2023 09:00 ET
|
SNS Insider pvt ltd
Pune, Nov. 20, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that the size of Neuroscience Market was projected to be USD 42.6 billion in 2022, with an anticipated growth to USD 65.8...
Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo
October 30, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
October 05, 2023 09:00 ET
|
Precision Neuroscience
NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems...
Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only FDA-approved biosimilar for relapsing forms of multiple sclerosis
August 25, 2023 01:15 ET
|
Novartis Pharma AG
Biosimilar Tyruko® approved for all indications of reference medicine, with same dosing and administration schedule Sandoz continues to expand access to much-needed medications for patients...
NysnoBio Awarded Michael J. Fox Foundation Grant to Advance Parkin Gene Therapy
July 17, 2023 16:05 ET
|
NysnoBio LLC
- The funding will support NB001 Parkin gene replacement therapy IND-enabling studies- Initial indication in a substantial, genetically defined Parkinson’s population: Parkin-PD- Parkin-PD mutations...
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
June 22, 2023 03:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Arvinas to Participate in Upcoming Investor Conferences
June 05, 2023 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
June 01, 2023 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts FIRDAPSE® 2023 Net Product Revenue Guidance of Between $245 Million and $255 Million, an...